Type to search

Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases | Pharmtech Focus
FDA Approves Repatha ® (evolocumab) in Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia | Pharmtech Focus
Amgen to Acquire Privately Held Teneobio for $900 Million in Cash With Future Contingent Milestone Payments | Pharmtech Focus